Milan – Sept. 4, 2020 – Greenberg Traurig Santa Maria assisted Berrier Capital fund and other minority shareholders, in the sale of Sidam Group - BTC Medical Europe, to Mandarin Capital.
Berrier Capital partners Marsupium and Annalisa Azzolini (daughter of the founder) have reinvested in the company MedTech, which acquired the group, with a relative minority interest. Together they represent over 30%. The operation saw the sale, against a parallel spin-off into a newco and transfer to two managers of the neurology activities of Synopo, of 100% of New Horizon S.p.A. to MedTech S.p.A., a company 68% owned by Mandarin Capital Partners III and the other partners, as mentioned. Crédit Agricole also participated with the disbursement of a loan to New Horizon S.p.A. aimed at the acquisition of the equity investment owned by Azzolini. The new majority shareholder confirmed the existing top management of the company as Chairman Carlo Bonomi and Managing Director Annalisa Azzolini. This, they noted, was in line with the plan of absolute continuity wanted by the new shareholder to support the growth and expansion plan of the Group.
The Greenberg Traurig Santa Maria team was led by shareholders Carlo Scaglioni and Federico Barbàra.
About Greenberg Traurig Santa Maria: is the result of the combination of Greenberg Traurig, LLP with its long-term ally, Santa Maria Studio Legale Associato - a renowned legal boutique, founded in 1970 by Alberto Santa Maria in Milan. Greenberg Traurig Santa Maria is the fifth GT office in Europe and the 40th office worldwide.
About Greenberg Traurig, LLP: Greenberg Traurig, LLP (GT) has approximately 2200 attorneys in 40 locations in the United States, Latin America, Europe, Asia, and the Middle East. GT has been recognized for its philanthropic giving, diversity, and innovation, and is consistently among the largest firms in the U.S. on the Law360 400 and among the Top 20 on the Am Law Global 100. Web: www.gtlaw.com Twitter: @GT_Law.